
Keywords: SK; sphingosine kinase; S1P; sphingosine-1-phosphate; BrdU; 5-bromo-2-deoxyuridine; I/R; ischemia/reperfusion; ELISA; enzyme-linked immunosorbant assay; PCNA; proliferating cell nuclear antigen; H3-P; phosphorylated histone H3; FSBA; fluorosulfonylbenzoyl